{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "OtherID": [], "GeneralNote": [], "KeywordList": [["biological markers", "cognitive frailty", "frailty", "neuropsychological markers", "oxygen\u2013ozone therapy", "randomized double-blind clinical trial"]], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "PMID": "39201987", "DateRevised": {"Year": "2024", "Month": "09", "Day": "01"}, "Article": {"ELocationID": ["795", "10.3390/jpm14080795"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "27"}], "Language": ["eng"], "Journal": {"ISSN": "2075-4426", "JournalIssue": {"Volume": "14", "Issue": "8", "PubDate": {"Year": "2024", "Month": "Jul", "Day": "27"}}, "Title": "Journal of personalized medicine", "ISOAbbreviation": "J Pers Med"}, "ArticleTitle": "Cognitive, Neuropsychological and Biological Effects of Oxygen-Ozone Therapy on Frailty: A Study Protocol for a 5-Week, Randomized, Placebo-Controlled Trial.", "Abstract": {"AbstractText": ["Cognitive frailty (CF) is a heterogeneous syndrome that is becoming one of the most serious health problems as the world's population age is increasing. Elucidating its biological mechanisms as well as prevention and treatments is becoming increasingly significant, particularly in view of the associated health costs. We presented the study protocol of a research project funded by the Italian Ministry of Health (grant number RF-2016-02363298) aiming to investigate the cognitive and neuropsychological effects of a 5-week treatment with therapy based on the regenerative properties of ozone (O<sub>3</sub>) in a cohort of subjects stratified according to CF scores. We also studied the potential effects of O<sub>3</sub> on blood-based biomarkers indicative of specific biological systems that may be altered in CF. Seventy-five older persons were recruited and randomly assigned to receive the active treatment (150 cc of oxygen-O<sub>2</sub>-O<sub>3</sub> mixture at the concentration of 30 \u00b5g of O<sub>3</sub> per cc of O<sub>2</sub>), O<sub>2</sub>, or the placebo (air) for 5 weeks. The main endpoints were the change in the scores of clinical scales from baseline (T0) to weeks 3 (T3), 9 (T9), and 15 (T15) after treatment and the change in biomarker levels resulting from transcriptomics, proteomics, and metabolomic patterns at the same times. The positive results from this study could have important clinical implications."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Biological Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": [], "LastName": "Scassellati", "ForeName": "Catia", "Initials": "C"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": ["0000-0003-1577-2823"], "LastName": "Bonvicini", "ForeName": "Cristian", "Initials": "C"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, University of Modena and Reggio Emilia, 41121 Modena, Italy."}], "Identifier": [], "LastName": "Ciani", "ForeName": "Miriam", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": ["0000-0001-7727-0584"], "LastName": "Zanardini", "ForeName": "Roberta", "Initials": "R"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": [], "LastName": "Tomasoni", "ForeName": "Evita", "Initials": "E"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": [], "LastName": "Saletti", "ForeName": "Valentina", "Initials": "V"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": [], "LastName": "Passeggia", "ForeName": "Ilaria", "Initials": "I"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Trial Service, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": ["0000-0002-5002-4591"], "LastName": "Almici", "ForeName": "Monica", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuropsychology Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": [], "LastName": "Pagnoni", "ForeName": "Ilaria", "Initials": "I"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Oxygen-Ozone Therapy Scientific Society (SIOOT), 24020 Gorle, Italy."}], "Identifier": [], "LastName": "Galoforo", "ForeName": "Antonio Carlo", "Initials": "AC"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Neuroscience, Italian National Research Council (CNR), 56124 Pisa, Italy."}, {"Identifier": [], "Affiliation": "Laboratory of Biology \"Bio@SNS\", Scuola Normale Superiore, 56124 Pisa, Italy."}], "Identifier": ["0000-0001-5821-9871"], "LastName": "Costa", "ForeName": "Mario", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "European Brain Research Institute (EBRI) Rita Levi-Montalcini, 00161 Rome, Italy."}], "Identifier": [], "LastName": "D'Onofrio", "ForeName": "Mara", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Biology \"Bio@SNS\", Scuola Normale Superiore, 56124 Pisa, Italy."}, {"Identifier": [], "Affiliation": "European Brain Research Institute (EBRI) Rita Levi-Montalcini, 00161 Rome, Italy."}], "Identifier": [], "LastName": "Cattaneo", "ForeName": "Antonino", "Initials": "A"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Alzheimer's Unit, Memory Clinic, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy."}], "Identifier": [], "LastName": "Geroldi", "ForeName": "Cristina", "Initials": "C"}], "GrantList": [{"GrantID": "RF-2016-02363298", "Agency": "Italian Ministry of Health", "Country": ""}, {"GrantID": "Ricerca Corrente", "Agency": "Italian Ministry of Health", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Pers Med", "NlmUniqueID": "101602269", "ISSNLinking": "2075-4426"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Chen X., Mao G., Leng S.X. Frailty syndrome: An overview. Clin. Interv. Aging. 2014;9:433\u2013441. doi: 10.2147/CIA.S45300.", "ArticleIdList": ["10.2147/CIA.S45300", "PMC3964027", "24672230"]}, {"Citation": "Clegg A., Young J., Iliffe S., Rikkert M.O., Rockwood K. Frailty in elderly people. Lancet. 2013;381:752\u2013762. doi: 10.1016/S0140-6736(12)62167-9.", "ArticleIdList": ["10.1016/S0140-6736(12)62167-9", "PMC4098658", "23395245"]}, {"Citation": "Lang P., Michel J., Zekry D. Frailty syndrome: A transitional state in a dynamic process. Gerontology. 2009;55:539\u2013549. doi: 10.1159/000211949.", "ArticleIdList": ["10.1159/000211949", "19346741"]}, {"Citation": "Robertson D.A., Savva G.M., Kenny R.A. Frailty and cognitive impairment\u2014A review of the evidence and causal mechanisms. Ageing Res. Rev. 2013;12:840\u2013851. doi: 10.1016/j.arr.2013.06.004.", "ArticleIdList": ["10.1016/j.arr.2013.06.004", "23831959"]}, {"Citation": "Chen C.Y., Gan P., How C.H. Approach to frailty in the elderly in primary care and the community. Singap. Med. J. 2018;59:240\u2013245. doi: 10.11622/smedj.2018052.", "ArticleIdList": ["10.11622/smedj.2018052", "PMC5966632", "29799055"]}, {"Citation": "Yang Q., Wang Y., Yang M., Ge S., Cheng S., Wang C., Zhang W., Tian C., Mao J. Apathy co-occurs with subjective cognitive decline among community-dwelling older adults. Geriatr. Nurs. 2022;48:177\u2013182. doi: 10.1016/j.gerinurse.2022.09.018.", "ArticleIdList": ["10.1016/j.gerinurse.2022.09.018", "36257223"]}, {"Citation": "Collard R.M., Boter H., Schoevers R.A., Oude Voshaar R.C. Prevalence of frailty in community-dwelling older persons: A systematic review. J. Am. Geriatr. Soc. 2012;60:1487\u20131492. doi: 10.1111/j.1532-5415.2012.04054.x.", "ArticleIdList": ["10.1111/j.1532-5415.2012.04054.x", "22881367"]}, {"Citation": "Yoon D.H., Hwang S.S., Lee D.W., Lee C.G., Song W. Physical Frailty and Cognitive Functioning in Korea Rural Community-Dwelling Older Adults. J. Clin. Med. 2018;7:405. doi: 10.3390/jcm7110405.", "ArticleIdList": ["10.3390/jcm7110405", "PMC6262608", "30384463"]}, {"Citation": "Fabricio D.d.M., Chagas M.H.N., Diniz B.S. Frailty and cognitive decline. Transl. Res. 2020;221:58\u201364. doi: 10.1016/j.trsl.2020.01.002.", "ArticleIdList": ["10.1016/j.trsl.2020.01.002", "32045578"]}, {"Citation": "Kelaiditi E., Cesari M., Canevelli M., van Kan G.A., Ousset P., Gillette-Guyonnet S., Ritz P., Duveau F., Soto M.E., Provencher V., et al. Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J. Nutr. Health Aging. 2013;17:726\u2013734. doi: 10.1007/s12603-013-0367-2.", "ArticleIdList": ["10.1007/s12603-013-0367-2", "24154642"]}, {"Citation": "Rivan N.F.M., Shahar S., Rajab N.F., Singh D.K.A., Che Din N., Mahadzir H., Mohamed Sakian N.I., Ishak W.S., Abd Rahman M.H., Mohammed Z., et al. Incidence and Predictors of Cognitive Frailty Among Older Adults: A Community-based Longitudinal Study. Int. J. Env. Res. Public Health. 2020;17:1547. doi: 10.3390/ijerph17051547.", "ArticleIdList": ["10.3390/ijerph17051547", "PMC7084438", "32121194"]}, {"Citation": "Panza F., Lozupone M., Solfrizzi V., Sardone R., Dibello V., Di Lena L., D\u2019Urso F., Stallone R., Petruzzi M., Giannelli G., et al. Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention. J. Alzheimers Dis. 2018;62:993\u20131012. doi: 10.3233/JAD-170963.", "ArticleIdList": ["10.3233/JAD-170963", "PMC5870024", "29562543"]}, {"Citation": "Chen G., Zhang H., Du X., Yin L., Zhang H., Zhou Q. Comparison of the prevalence and associated factors of cognitive frailty between elderly and middle-young patients receiving maintenance hemodialysis. Int. Urol. Nephrol. 2022;54:2703\u20132711. doi: 10.1007/s11255-022-03188-3.", "ArticleIdList": ["10.1007/s11255-022-03188-3", "PMC9463251", "35366144"]}, {"Citation": "Buchman A.S., Boyle P.A., Wilson R.S., Tang Y., Bennett D.A. Frailty is associated with incident Alzheimer\u2019s disease and cognitive decline in the elderly. Psychosom. Med. 2007;69:483\u2013489. doi: 10.1097/psy.0b013e318068de1d.", "ArticleIdList": ["10.1097/psy.0b013e318068de1d", "17556640"]}, {"Citation": "Boyle P.A., Buchman A.S., Wilson R.S., Leurgans S.E., Bennett D.A. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J. Am. Geriatr. Soc. 2010;58:248\u2013255. doi: 10.1111/j.1532-5415.2009.02671.x.", "ArticleIdList": ["10.1111/j.1532-5415.2009.02671.x", "PMC3150526", "20070417"]}, {"Citation": "Chand G.B., Wu J., Hajjar I., Qiu D. Interactions of the Salience Network and Its Subsystems with the Default-Mode and the Central-Executive Networks in Normal Aging and Mild Cognitive Impairment. Brain Connect. 2017;7:401\u2013412. doi: 10.1089/brain.2017.0509.", "ArticleIdList": ["10.1089/brain.2017.0509", "PMC5647507", "28707959"]}, {"Citation": "Yeager B.E., Twedt H.P., Bruss J., Schultz J., Narayanan N.S. Salience network and cognitive impairment in Parkinson\u2019s disease. medRxiv. 2023 doi: 10.1101/2023.10.13.23296825.", "ArticleIdList": ["10.1101/2023.10.13.23296825", "PMC11066685", "38677099"]}, {"Citation": "Qiu Y., Li G., Wang X., Zheng L., Wang C., Wang C., Chen L. Prevalence of cognitive frailty among community-dwelling older adults: A systematic review and meta-analysis. Int. J. Nurs. Stud. 2022;125:104112. doi: 10.1016/j.ijnurstu.2021.104112.", "ArticleIdList": ["10.1016/j.ijnurstu.2021.104112", "34758429"]}, {"Citation": "Sugimoto T., Arai H., Sakurai T. An update on cognitive frailty: Its definition, impact, associated factors and underlying mechanisms, and interventions. Geriatr. Gerontol. Int. 2022;22:99\u2013109. doi: 10.1111/ggi.14322.", "ArticleIdList": ["10.1111/ggi.14322", "34882939"]}, {"Citation": "Pothier K., Gana W., Bailly N., Fougere B. Associations Between Frailty and Inflammation, Physical, and Psycho-Social Health in Older Adults: A Systematic Review. Front. Psychol. 2022;13:805501. doi: 10.3389/fpsyg.2022.805501.", "ArticleIdList": ["10.3389/fpsyg.2022.805501", "PMC8963891", "35360636"]}, {"Citation": "Di Meo S., Venditti P. Evolution of the Knowledge of Free Radicals and Other Oxidants. Oxid. Med. Cell. Longev. 2020;2020:9829176. doi: 10.1155/2020/9829176.", "ArticleIdList": ["10.1155/2020/9829176", "PMC7201853", "32411336"]}, {"Citation": "Baranova I.V., Bezsmertnyi Y.A., Bezsmertnaya H.V., Postovitenko K.P., Iliuk I.A., Gumeniuk A.F. Analgetic effect of ozone therapy: Myths of reality? Pol. Ann. Med. 2020;27:62\u201367."}, {"Citation": "Masan J., Sramka M., Rabarova D. The possibilities of using the effects of ozone therapy in neurology. Neuro Endocrinol. Lett. 2021;42:13\u201321.", "ArticleIdList": ["33932964"]}, {"Citation": "Galie M., Covi V., Tabaracci G., Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int. J. Mol. Sci. 2019;20:4009. doi: 10.3390/ijms20164009.", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Smith N.L., Wilson A.L., Gandhi J., Vatsia S., Khan S.A. Ozone therapy: An overview of pharmacodynamics, current research, and clinical utility. Med. Gas. Res. 2017;7:212\u2013219. doi: 10.4103/2045-9912.215752.", "ArticleIdList": ["10.4103/2045-9912.215752", "PMC5674660", "29152215"]}, {"Citation": "Viebahn-Haensler R., Leon Fernandez O.S. Ozone in Medicine. The Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases. Int. J. Mol. Sci. 2021;22:7890. doi: 10.3390/ijms22157890.", "ArticleIdList": ["10.3390/ijms22157890", "PMC8346137", "34360655"]}, {"Citation": "Safwat M.H., El-Sawalhi M.M., Mausouf M.N., Shaheen A.A. Ozone ameliorates age-related oxidative stress changes in rat liver and kidney: Effects of pre- and post-ageing administration. Biochemistry. 2014;79:450\u2013458. doi: 10.1134/S0006297914050095.", "ArticleIdList": ["10.1134/S0006297914050095", "24954596"]}, {"Citation": "Lin S., Ma J., An J., Qian X., Wang Y., Cope D.K., Williams J.P. Ozone Inhibits APP/Abeta Production and Improves Cognition in an APP/PS1 Transgenic Mouse Model. Neuroscience. 2019;418:110\u2013121. doi: 10.1016/j.neuroscience.2019.07.027.", "ArticleIdList": ["10.1016/j.neuroscience.2019.07.027", "31349006"]}, {"Citation": "El-Sawalhi M.M., Darwish H.A., Mausouf M.N., Shaheen A.A. Modulation of age-related changes in oxidative stress markers and energy status in the rat heart and hippocampus: A significant role for ozone therapy. Cell Biochem. Funct. 2013;31:518\u2013525. doi: 10.1002/cbf.2930.", "ArticleIdList": ["10.1002/cbf.2930", "23172693"]}, {"Citation": "Shehata N.I., Abd-Elgawad H.M., Mawsouf M.N., Shaheen A.A. The potential role of ozone in ameliorating the age-related biochemical changes in male rat cerebral cortex. Biogerontology. 2012;13:565\u2013581. doi: 10.1007/s10522-012-9400-9.", "ArticleIdList": ["10.1007/s10522-012-9400-9", "23001537"]}, {"Citation": "Abete P., Basile C., Bulli G., Curcio F., Liguori I., Della-Morte D., Gargiulo G., Langellotto A., Testa G., Galizia G., et al. The Italian version of the \u201cfrailty index\u201d based on deficits in health: A validation study. Aging Clin. Exp. Res. 2017;29:913\u2013926. doi: 10.1007/s40520-017-0793-9.", "ArticleIdList": ["10.1007/s40520-017-0793-9", "28688080"]}, {"Citation": "Romero-Ortuno R. The Frailty Instrument of the Survey of Health, Ageing and Retirement in Europe (SHARE-FI) predicts mortality beyond age, comorbidities, disability, self-rated health, education and depression. Eur. Geriatr. Med. 2011;2:323\u2013326. doi: 10.1016/j.eurger.2011.08.005.", "ArticleIdList": ["10.1016/j.eurger.2011.08.005", "PMC3237697", "22180765"]}, {"Citation": "Folstein M.F., Folstein S.E., McHugh P.R. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189\u2013198. doi: 10.1016/0022-3956(75)90026-6.", "ArticleIdList": ["10.1016/0022-3956(75)90026-6", "1202204"]}, {"Citation": "Cotelli M., Manenti R., Brambilla M., Petesi M., Rosini S., Ferrari C., Zanetti O., Miniussi C. Anodal tDCS during face-name associations memory training in Alzheimer\u2019s patients. Front. Aging Neurosci. 2014;6:38. doi: 10.3389/fnagi.2014.00038.", "ArticleIdList": ["10.3389/fnagi.2014.00038", "PMC3958642", "24678298"]}, {"Citation": "De Renzi E., Motti F., Nichelli P. Imitating gestures. A quantitative approach to ideomotor apraxia. Arch. Neurol. 1980;37:6\u201310. doi: 10.1001/archneur.1980.00500500036003.", "ArticleIdList": ["10.1001/archneur.1980.00500500036003", "7350907"]}, {"Citation": "Arisi I., Malimpensa L., Manzini V., Brandi R., Gosetti di Sturmeck T., D\u2019Amelio C., Crisafulli S., Ferrazzano G., Belvisi D., Malerba F., et al. Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients. Front. Immunol. 2023;14:1234869. doi: 10.3389/fimmu.2023.1234869.", "ArticleIdList": ["10.3389/fimmu.2023.1234869", "PMC10751352", "38152407"]}, {"Citation": "Caputo V., Pacilli M.G., Arisi I., Mazza T., Brandi R., Traversa A., Casasanta G., Pisa E., Sonnessa M., Healey B., et al. Genomic and physiological resilience in extreme environments are associated with a secure attachment style. Transl. Psychiatry. 2020;10:185. doi: 10.1038/s41398-020-00869-4.", "ArticleIdList": ["10.1038/s41398-020-00869-4", "PMC7283351", "32518224"]}, {"Citation": "Elvis A.M., Ekta J.S. Ozone therapy: A clinical review. J. Nat. Sci. Biol. Med. 2011;2:66\u201370. doi: 10.4103/0976-9668.82319.", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "Re L., Malcangi G., Martinez-Sanchez G. Medical ozone is now ready for a scientific challenge: Current status and future perspectives. J. Exp. Integr. Med. 2012;2:193\u2013196. doi: 10.5455/jeim.070612.ir.012.", "ArticleIdList": ["10.5455/jeim.070612.ir.012"]}, {"Citation": "Scassellati C., Galoforo A.C., Bonvicini C., Esposito C., Ricevuti G. Ozone: A natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing Res. Rev. 2020;63:101138. doi: 10.1016/j.arr.2020.101138.", "ArticleIdList": ["10.1016/j.arr.2020.101138", "PMC7428719", "32810649"]}, {"Citation": "Bocci V. OZONE: A New Medical Drug. Springer; Dordrecht, The Netherlands: 2010."}, {"Citation": "Schwartz A., S\u00e1nchez G.M., Cum L., Quintero R., Mccarthy W., Moreno O. Madrid Declaration on Ozone Therapy. 3rd ed. The International Scientific Committee of Ozone Therapy; Madrid, Spain: 2020. Official document of ISCO3."}, {"Citation": "Facal D., Burgo C., Spuch C., Gaspar P., Campos-Magdaleno M. Cognitive Frailty: An Update. Front. Psychol. 2021;12:813398. doi: 10.3389/fpsyg.2021.813398.", "ArticleIdList": ["10.3389/fpsyg.2021.813398", "PMC8717771", "34975703"]}, {"Citation": "Rietman M.L., Hulsegge G., Nooyens A.C.J., Dolle M.E.T., Picavet H.S.J., Bakker S.J.L., Gansevoort R.T., Spijkerman A.M.W., Verschuren W.M.M. Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study. Front. Neurol. 2019;10:497. doi: 10.3389/fneur.2019.00497.", "ArticleIdList": ["10.3389/fneur.2019.00497", "PMC6555275", "31214102"]}, {"Citation": "Royall D.R., Palmer R.F. Alzheimer\u2019s Disease Neuroimaging Initiative Blood-based protein mediators of senility with replications across biofluids and cohorts. Brain Commun. 2019;2:fcz036. doi: 10.1093/braincomms/fcz036.", "ArticleIdList": ["10.1093/braincomms/fcz036", "PMC7425523", "32954311"]}, {"Citation": "Sargent L., Nalls M., Amella E.J., Slattum P.W., Mueller M., Bandinelli S., Tian Q., Swift-Scanlan T., Lageman S.K., Singleton A. Shared mechanisms for cognitive impairment and physical frailty: A model for complex systems. Alzheimers Dement. 2020;6:e12027. doi: 10.1002/trc2.12027.", "ArticleIdList": ["10.1002/trc2.12027", "PMC7362211", "32685657"]}, {"Citation": "He W., Luo Y., Liu J., Sun N., Guo D., Cui L., Zheng P., Yao S., Yang J., Wang H. Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease. Clin. Interv. Aging. 2020;15:1809\u20131820. doi: 10.2147/CIA.S270887.", "ArticleIdList": ["10.2147/CIA.S270887", "PMC7534046", "33061331"]}, {"Citation": "Bonvicini C., Geroldi C., Scassellati C. Raw Data Paper: Clinic and NPS Data. Zenodo; Geneve, Switzerland: 2024. [Data set]"}]}], "History": [{"Year": "2024", "Month": "6", "Day": "17"}, {"Year": "2024", "Month": "7", "Day": "8"}, {"Year": "2024", "Month": "7", "Day": "25"}, {"Year": "2024", "Month": "8", "Day": "31", "Hour": "9", "Minute": "54"}, {"Year": "2024", "Month": "8", "Day": "31", "Hour": "9", "Minute": "53"}, {"Year": "2024", "Month": "8", "Day": "29", "Hour": "1", "Minute": "16"}, {"Year": "2024", "Month": "7", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["39201987", "PMC11355685", "10.3390/jpm14080795", "jpm14080795"]}}], "PubmedBookArticle": []}